The FDA announced on May 14, 2026, that Fresenius Kabi USA, LLC is recalling Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vials due to failed impurities and degradations specifications. The voluntary Class III recall affects 898,050 units distributed nationwide.
How to tell if you have it
- Brand: Fresenius Kabi
- Product: Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vial
- NDC 63323-696-02 (vial), NDC 63323-696-25 (carton)
- Batch # 6133313, Exp Date: 06/2026
- Batch # 6133314, Exp Date: 06/2026
- Batch # 6133315, Exp Date: 07/2026
- Batch # 6133682, Exp Date: 09/2026
- Batch # 6134812, Exp Date: 04/2027
- Batch # 6134813, Exp Date: 04/2027
The hazard
The recall is due to failed impurities and degradations specifications. The FDA reported no specific incidents or injuries associated with this recall in the provided record.
Context
GovInfoNow's records show Fresenius Kabi USA, LLC has 65 other recalls on record since 2012-09-27. Other recent recalls of similar products include Fresenius Kabi Tyenne Injection Recall (2026-08-10), Fresen: Morphine Syringes May Have Wrong Labeling (2026-08-04), and Fresenius Kabi Lidocaine HCl Injection Recall (2026-07-16). Other recent recalls of similar products include Fresenius Kabi Ketamine HCl Injection Recall (2026-02-05), American Regent Epinephrine Injection Recall (2026-08-11), and EPINEPHR: Sterility Risk in 1 mg/10mL Injection Recall (2026-04-01).